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Ceapins block the unfolded protein response sensor ATF6α by inducing a 
neomorphic inter-organelle tether 
 
By 
 
Sandra Elizabeth Torres 
 
 
 
ABSTRACT 
 
The unfolded protein response (UPR) detects and restores deficits in the 
endoplasmic reticulum (ER) protein folding capacity. Ceapins specifically inhibit the 
UPR sensor ATF6α, an ER-tethered transcription factor, by retaining it at the ER 
through an unknown mechanism. Our genome-wide CRISPR interference (CRISPRi) 
screen reveals that Ceapins function is completely dependent on the ABCD3 
peroxisomal transporter. Proteomics studies establish that ABCD3 physically associates 
with ER-resident ATF6α in cells and in vitro in a Ceapin-dependent manner. Ceapins 
induce the neomorphic association of ER and peroxisomes by directly tethering the 
cytosolic domain of ATF6α to ABCD3’s transmembrane regions without inhibiting or 
depending on ABCD3 transporter activity. Thus, our studies reveal that Ceapins 
function by chemical-induced misdirection which explains their remarkable specificity 
and opens up new mechanistic routes for drug development and synthetic biology. 
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CHAPTER ONE 
 
Introduction and Review  
  
2 
Introduction 
Most secreted and transmembrane proteins are folded and assembled in the 
endoplasmic reticulum. When ER homeostasis is disturbed, misfolded proteins 
accumulate, ultimately leading to toxic aggregates and apoptosis. Under ER stress, the 
unfolded protein response is activated to deal with misfolded proteins by decreasing the 
ER protein influx, increasing ER volume and protein folding capacity, and activating the 
ER-associated degradation (ERAD) pathway (Walter and Ron, 2011). The ER 
transmembrane sensors, IRE1, PERK, and ATF6α, mediate the UPR signaling cascade 
to activate UPR target genes. ATF6α plays a key role in the UPR by transcriptionally 
upregulating ER-resident chaperones and folding enzymes. ATF6α is necessary for cell 
survival in the presence of stress. ATF6α knockout mouse embryonic fibroblast cells are 
viable, but they die in the presence of ER stress-inducing agents (Wu et al., 2007; 
Yamamoto et al., 2007).  Activation of ATF6α in cardiomyocytes is also protective 
against cardiac injury (Lynch et al, 2012).  
ATF6α is an ER-tethered transcription factor with a cytosolic transactivation 
domain and a stress-sensing ER luminal domain (Haze et al.,1999;Yoshida et al., 
1998). ATF6α exists as an oligomer, dimer, and monomer at the ER (Nadanaka et al., 
2007). Upon ER stress, ATF6α is packaged into COPII transport vesicles that deliver it 
to the Golgi apparatus, where it is cleaved by S1P and S2P (site-1 and site-2 protease) 
(Nadanaka et al., 2004; Okada et al., 2003; Schindler and Schekman, 2009; Ye et al., 
2000). This proteolysis releases the N-terminal cytosolic fragment, ATF6α-N, which then 
moves into the nucleus to activate its UPR target genes. After prolonged ER stress, 
ATF6α shuts off and foci are seen in the ER (Gallagher et al., 2016; Rutkowski et al., 
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2006; Haze et al., 2001) Although the downstream ATF6α transcriptional targets have 
been characterized, the mechanism by which ATF6α is activated in the ER allowing it to 
enter transport vesicles remains unclear.  
 For ER stress to induce ATF6α signaling, ATF6α must first sense an imbalance 
in protein folding in the ER lumen. ATF6α must then engage with the trafficking 
machinery to be transported to the Golgi apparatus. Although the mechanism for ATF6α 
activation and trafficking remain unknown, several models of ATF6α activation have 
been proposed. In one model, the ATF6α oligomeric state occludes a trafficking signal 
that becomes accessible when stress triggers the dissociation of the ATF6α oligomer 
into the monomer. Fractionation studies show that is an ATF6α monomer that traffics to 
the Golgi. However, mutating two conserved cysteines in ATF6α (C467A & C618A), to 
generate ATF6α monomers did not lead to constitutive ATF6α trafficking (Nadanaka et 
al., 2007). Thus, ATF6α exists as a monomer, dimer, and oligomer in unstressed ER 
and is reduced in response to ER stress, allowing the reduced monomer to traffic to the 
Golgi. However, the additional factors, conformational changes, or licensing steps 
required for the monomer to traffic remain unclear.  
In an alternative model, a putative retention factor binds to ATF6α and upon ER 
stress it dissociates. Although BiP has been proposed to be such retention factor (Shen 
et al., 2005), it is one of the most abundant ER chaperones, present in the ER in 
millimolar concentrations. It follows that huge amounts of unfolded proteins would need 
to accumulate for BiP to be saturated and dissociate from ATF6α to activate it. 
Moreover, this event would need to occur quickly, since ATF6α-N can be detected 
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within 15 minutes of treatment with DTT (ER stress inducing agent) (Nadanaka et al., 
2007).  
A third model most similar to the another notable ER tethered transcription factor, 
SREBP, is also appealing. In this model, stress triggers dissociation of a retention factor 
and ATF6α bound to a constitutive trafficking receptor is now able to traffic to the Golgi 
apparatus. SREBP responds to low sterol levels, ultimately upregulating genes involved 
in cholesterol uptake and biosynthesis. SREBP is constitutively bound to its trafficking 
receptor, SCAP, which has a COPII binding site that is accessible in the absence of 
sterols (Brown et al 2009). When sterol levels are high, sterols and the retention factor, 
INSIG, bind to SCAP causing a conformational change that occludes the COPII binding 
site (Yang et al., 2002). Once sterol levels decrease, INSIG dissociates and the COPII 
binding site on SCAP becomes accessible (Sun et al., 2005). In a similar manner, 
ATF6α tracking may also require additional components, perhaps comprising the 
equivalent of a trafficking receptor(s) like SCAP and a retention factor(s) like INSIG. 
Ultimately, an unbiased and robust means of probing the ATF6α pathway to determine 
which model, if any or a combination of all, describes the mechanism of ATF6α 
activation and trafficking.   
 A series of selective small molecule ATF6α inhibitors (Ceapins) were identified 
from a high-throughput cell-based screen of over 100,000 compounds (Gallagher et al., 
2016) and provides a new means of proving ATF6α interactions in the ER. Ceapins 
selectively block ATF6α signaling and do not inhibit the other UPR sensors, Golgi 
proteases, ATF6b, or SREBP. Ceapin induces the striking formation of ATF6α foci that 
are reversible upon washout. These foci are excluded from ER exit sites. When the 
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trafficking requirement is removed by collapsing the Golgi into the ER with BFA 
treatment, making the Golgi proteases accessible, ATF6α in Ceapin induced foci are 
still cleavable (Gallagher et al., 2016). The identification of such a specific small 
molecule inhibitor to ATF6α, given ATF6α’s use of general COPII trafficking and Golgi 
proteases, is remarkable.  
 Ceapin induces ATF6α foci that look quite similar to the stress attenuated 
ATF6α foci that form during prolonged ER stress (Gallagher et al., 2016). Given 
Ceapins’ striking specificity to ATF6α, this led to a model where Ceapin stabilized the 
normal retention or attenuated ATF6α state. Since little is known of this attenuated 
ATF6α state, Ceapins provided a new means to probe the ATF6α pathway. We initially 
expected the target of Ceapin to converge on a component of the ATF6α pathway and 
elucidate the mechanism of ATF6α activation and trafficking. In this dissertation, I utilize 
unbiased genetic and complimentary biochemical approaches to identify the molecular 
target of Ceapin and instead uncover an unprecedented means of small-molecule 
induced protein sequestration.  
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Introduction 
The endoplasmic reticulum (ER) is the site of folding and assembly of secreted 
and transmembrane proteins. When ER homeostasis is disturbed, misfolded proteins 
accumulate and activate the unfolded protein response (UPR) (Walter and Ron, 2011). 
One of the ER-resident UPR sensors, ATF6α, is an ER-tethered transcription factor that 
is cytoprotective and necessary for cell survival when cells experience ER stress (Wu et 
al., 2007; Yamamoto et al., 2007). Under stress conditions, ATF6α traffics to the Golgi 
apparatus, where it undergoes intramembrane proteolysis, releasing a bZIP 
transcription factor domain that moves to the nucleus and activates transcription (Haze 
et al.,1999;Yoshida et al., 1998). The events leading to ATF6α activation and trafficking 
remain poorly understood, but require the Golgi-resident proteases S1P and S2P and 
general components involved in COPII trafficking (Nadanaka et al., 2004; Okada et al., 
2003; Schindler and Schekman, 2009; Ye et al., 2000) that are not specific to ATF6α.  
Using a cell-based high-throughput screen, we recently identified a series of 
selective small-molecule inhibitors of ATF6α signaling, termed Ceapins (from the Irish 
verb “ceap” meaning “to trap”) (Gallagher et al., 2016). Ceapins act on the most 
upstream step of ATF6α activation by retaining ATF6α at the ER and excluding it from 
ER exit sites during ER stress. When this trafficking requirement is removed by 
collapsing the Golgi apparatus into the ER, making ATF6α accessible to S1P and S2P, 
ATF6α is still cleavable by the proteases in the presence of Ceapin. Upon Ceapin 
treatment, ATF6α rapidly and reversibly forms foci without requiring new protein 
synthesis (Gallagher et al., 2016; Gallagher & Walter, 2016). The molecular target(s) of 
Ceapins, let alone how Ceapins specifically inhibit ATF6α, especially in light of the fact 
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that activation depends on components that are shared by other cellular process, have 
remained an enigma. 
To identify the molecular target of Ceapin, we carried out an unbiased genome-
wide screen and proteomic analysis. Our approaches converged on a single target, the 
peroxisomal transporter ABCD3. ATF6α and ABCD3 normally do not interact and, 
indeed, localize to different parts of the cell. Ceapins induce these novel physical 
associations between ATF6α and ABCD3 in cells and in vitro. Our results indicate that 
Ceapins achieve their remarkable specificity through an unprecedented mechanism of 
small molecule induced inter-organelle tethering.  
 
Results 
To decipher the molecular mechanism of Ceapins, we carried out a genome-wide 
CRISPR interference (CRISPRi) screen to identify genes whose knockdown (KD) 
resulted in reduced or enhanced sensitivity to the drug. To this end, we screened a 
genome-wide sgRNA library (Horlbeck et al., 2016) in K562 cells that stably expressed 
dCas9-KRAB and an mCherry transcriptional reporter dependent on ATF6α activation 
(Figure 2.1A). Treatment with tunicamycin (Tm), which blocks N-linked glycosylation, 
activates ATF6α signaling leading to a two-fold reporter induction that was completely 
dependent on ATF6α (Figure 2.1A). As a positive control, knocking down MBTPS2, one 
of the Golgi proteases that processes ATF6α, also inhibited induction of the reporter 
(Figure 2.2A), whereas knocking down HSPA5, encoding the major Hsp70-type ER 
chaperone BiP (Binding Protein), induced ER stress and the reporter constitutively 
(Figure 2.2B).   
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To carry out our genome-wide screen, we transduced the K562 ATF6α reporter 
cell line and selected for sgRNA expressing cells. We then induced ER stress with Tm 
in the presence or absence of Ceapin-A7, a potent member of the Ceapin family, and 
sorted cells by FACS (fluorescence-activated cell sorting). We isolated populations with 
decreased or increased ATF6α signaling (bottom 30% and top 30% of the reporter 
signal distributions, respectively) and used next-generation sequencing to quantify 
frequencies of cells expressing each sgRNA in both pools to evaluate how expression 
of each individual sgRNA affects activation of the ATF6α reporter (Adamson et al., 
2016; Sidrauski et al., 2015) (Figure 2.1B).  
As expected, KD of ATF6α or MBTPS2 (encoding S2P) inhibited reporter 
induction (Figure 2.1C). Knocking down abundant ER quality control components such 
as HSPA5, induced ER stress and turned on the reporter independently of Ceapin 
treatment (labeled in red in Figure 2.1C, Figure 2.2C-D). Ceapin independent genes 
localized to the diagonal because their knockdown changed the expression of the 
reporter to the same degree in both treatments (labeled in red in Figure 2.2C). Of 
particular interest were genes whose KD specifically made cells insensitive to Ceapin 
treatment allowing activation of the reporter by Tm in the presence of Ceapin (labeled in 
black in Figure 2.2C). Two genes, ABCD3 and PEX19, robustly retested among the 
more than twenty hits from the genetic screen we individually knocked down and tested 
in the ERSE reporter cell line.  
ABCD3, which encodes a peroxisomal ABC transporter involved in long-chain 
fatty acid import into peroxisomes, desensitized cells to Ceapin treatment (Figure 2.1C, 
Figure 2.2C-D). Additionally, PEX19, which is necessary for chaperoning and targeting 
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ABCD3 to the peroxisome, also desensitized cells to Ceapin treatment (Figure 2.1C, 
Figure 2.2C-D).  We knocked down these candidates individually and performed ERSE-
mCherry dose response assays using Tm. Retesting of these candidates revealed that 
ABCD3 and PEX19 KD cells remained completely insensitive to Ceapin-A7 at saturating 
concentrations (Figure 2.1D, Figure 2.7). To determine if ATF6α trafficking, processing, 
or activation is altered in ABCD3 KD cells, we then measured ATF6α nuclear 
translocation (Figure 2.3) and the downstream ATF6α-N activation of the reporter and 
endogenous ATF6α target genes HSPA5 and HSP90B1 (Figure 2.1E-G). In the 
absence of ER stress,  ABCD3 or PEX19 KD cells also do not cause constitutive 
nuclear translocation nor activate ATF6α (Figure 2.1E-G, Figure 2.3, Figure 2.7B). 
Furthermore, in the presence of ER stress, ABCD3 or PEX19 KD alone did not impede 
ATF6α nuclear translocation nor activation (Figure 2.1E-G, Figure 2.7B). These results 
indicate that neither ABCD3 nor PEX19 have direct roles in ATF6α signaling, posing the 
question of how Ceapins functionally connect proteins that reside in separate 
organelles.  
Ceapin treatment induces rapid and reversible formation of ATF6α foci that are 
retained in the ER (Figure 2.4A) (Gallagher et al., 2016; Gallagher & Walter, 2016). We 
next tested if ABCD3 was directly involved in the formation of these foci and would 
colocalize with ATF6α. Indeed, in Ceapin-treated cells, ATF6α colocalized with ABCD3 
as visualized by immunofluorescence (Figure 2.4A-B). This result was surprising 
because newly synthesized ABCD3 is inserted directly into the peroxisomal membrane 
using PEX19 as import receptor (Imanaka et al., 1996; Biermanns and Gärtner, 2001; 
Kashiwayama et al., 2007; Kashiwayama et al., 2005; Sacksteder et al., 2000). ABCD3 
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is not co-translationally translocated into the ER, indicating there is not a pool of ABCD3 
in the ER (Figure 2.5) (Jan et al., 2014); indeed, it is commonly used as a reliable 
marker for peroxisomes (Uhlén et al., 2015). Since both ABCD3 and PEX19 scored as 
hits in our screen, it seemed plausible that Ceapin induces ATF6α colocalization with 
peroxisomal ABCD3. We next tested whether ATF6α also colocalized with other 
peroxisomal markers, peroxisomal membrane protein PEX14 and peroxisomal matrix 
protein Thiolase (a maker for mature import competent peroxisomes).  In the absence of 
Ceapin, ATF6α and PEX14 or Thiolase did not colocalize (Figure 2.4A, C, Figure 2.6). 
By contrast, in the presence of Ceapin, we observed ATF6α and PEX14 and Thiolase 
colocalization (Figure 2.4A, C Figure 2.6). Furthermore, in ABCD3 KD cells treated with 
Ceapin, ATF6α no longer formed foci or colocalized with peroxisomes (Figure 2.4A, C). 
This result was consistent in PEX19 KD cells, where peroxisome biogenesis is affected 
and ABCD3 is no longer chaperoned and targeted to the peroxisome (Kashiwayama et 
al., 2007; Kashiwayama et al., 2005; Sacksteder et al., 2000), ATF6α no longer formed 
foci in the presence of Ceapin (Figure 2.7C). Thus, peroxisomes interact with Ceapin-
induced ATF6α foci in an ABCD3-dependent fashion to sequester ATF6α at the ER.   
After prolonged ER stress, ATF6α attenuates and forms foci that are reminiscent 
of Ceapin induced foci (Gallagher & Walter, 2016). We next asked whether Ceapin was 
acting on the normal mechanism of ATF6α attenuation by testing ABCD3 colocalization 
with stress attenuated ATF6α foci. To induce stress attenuated ATF6α foci, we treated 
U2OS cells expressing GFP-ATF6α with ER stress, Tm or Tg (thapsigargin, which 
inhibits the ER calcium pump) for 2 and 4 hours. In positive control cells treated with 
Ceapin, ATF6α colocalized with ABCD3 and PEX14. In stress induced cells, attenuated 
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ATF6α foci did not colocalize with ABCD3 or PEX14 by immunofluorescence (Figure 
2.4D-E). Thus, Ceapin does not act on the ATF6α pathway by stabilizing the attenuated 
ATF6α state. The stress attenuated foci and Ceapin induced foci are distinct.  
Since Ceapin treatment inhibits ATF6α, we next tested whether Ceapin treatment 
also inhibits ABCD3. ABCD3 knockout mice and hepatocytes display defects in bile acid 
biosynthesis (Ferdinandusse et al., 2015). To test if Ceapin treatment affects ABCD3 
activity, we measured bile acid levels in a liver cancer cell line (HepG2) after Ceapin 
treatment and ABCD3 KD. As expected, in ABCD3 KD cells, bile acid levels were 
decreased (Figure 2.8). In control cells treated at the EC50 and ten-times the EC50 of 
Ceapin, bile acid levels were similar to cells treated with vehicle only (Figure 2.8). Thus, 
Ceapin does not inhibit ABCD3 activity in cells.  
The tight association between the ER and peroxisome is mediated by ER-
peroxisome tethers, VAPA and VAPB on the ER and ACBD4 and ACBD5 on the 
peroxisomes (Costello et al., 2017; Costello et al., 2017; Hua et al., 2017). While the ER 
components are redundant, ACBD5 KD or overexpression alone decreases or increase 
ER-peroxisome contacts, respectively (Costello et al., 2017; Hua et al., 2017). To 
determine whether proximity between the ER and peroxisomes induced by these 
tethers is required for Ceapin-induced foci formation, we knocked-down these known 
ER-peroxisome tethers. In tether KD cells treated with Ceapin, ATF6α foci still formed 
and ATF6α colocalized with ABCD3 (Figure 2.9A-B). Additionally, tether KD cells were 
not resistant to Ceapin treatment (Figure 2.9C), consistent with the results from our 
screen in which these components also did not score as hits.  
16 
We next tested if ER membrane association of ATF6α is required for Ceapin 
induced foci. To this end, we knocked down endogenous ATF6α and FACS sorted for a 
narrow, low level of GFP expression for truncated variants of ATF6α containing its 
cytosolic regions without the transmembrane and ER-lumenal domains (Figure 2.10A). 
We found that GFP-ATF6α(2-302), which was retained in the cytosol with a nuclear exit 
signal and was no longer associated with the ER,  colocalized with ABCD3 and formed 
foci (Figure 2.10A-B). Further truncations showed that only the first 89 amino acids of 
ATF6α were both necessary and sufficient for Ceapin-dependent foci formation and 
colocalization with ABCD3 and peroxisomes (Figure 2.10A-B, Figure 2.11).  
Since ABCD3 is a transporter, we then tested if ABCD3 catalytic activity was 
required for Ceapin action. Similarly to our ATF6α truncations, we also knocked down 
endogenous ABCD3 and FACS sorted for low level GFP expression of constructs with 
mutations of ABCD3 residues that mediate ATP binding (G478R) and hydrolysis (S572I) 
or a deletion of the entire catalytic domain (Roerig et al.,  2001). There is one reported 
patient with a C terminal truncation of ABCD3 in which a reduced number of import 
competent peroxisomes are present (Ferdinandusse et al., 2015).  Similarly, GFP-
ABCD3DNBD cells, with a deletion of the entire catalytic domain, have reduced, 
enlarged peroxisomes (Figure 2.10C, Figure 2.12). We also confirmed correct 
localization of the GFP-ABCD3 constructs to the peroxisome (Figure 2.12). As a 
positive control, ABCD3 KD cells complemented with the full length ABCD3 construct 
were able to colocalize with and form ATF6α foci when treated with Ceapin (Figure 
2.10C-D).  In our catalytic activity mutants, we found that ABCD3 ATP binding or 
hydrolysis was not required for Ceapin-induced foci formation (Figure 2.10C-D).  
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Although there are fewer larger peroxisomes in GFP- ABCD3DNBD cells, peroxisomal 
ABCD3 still induced foci formation and colocalized with ATF6α in the presence of 
Ceapin (Figure 2.10C-D). These results indicate that Ceapin-induced interactions do not 
require ER localized ATF6α nor ABCD3 transporter activity.  
To identify components physically associating with ATF6α in the presence of 
Ceapin, we carried out native immunoprecipitation – mass spectrometric (IP-MS) 
analyses. We treated 3xFLAG-ATF6α HEK293 cells with Ceapin-A7 or an inactive 
analog, Ceapin-A5, in the presence of stress (Tg) and found that ABCD3 co-purified as 
the top hit with epitope-tagged ATF6α selectively in the presence of active Ceapin-A7 
but not inactive Ceapin-A5 (Figure 2.13A-B). The native reciprocal affinity purification 
with full-length GFP-ABCD3 cells confirmed these results (Figure 2.13C). Furthermore, 
GFP-ABCD3DNBD, lacking the entire nucleotide binding domain, also physically 
associated with ATF6α in the presence of Ceapin (Figure 2.13C). 
We then tested if the minimal cytosolic domain of ATF6α, GFP-ATF6α(2-90), 
physically associated with peroxisomal ABCD3. We immunoprecipitated GFP-ATF6α(2-
90) from detergent solubilized lysates and specifically enriched ABCD3 in the presence 
of active Ceapin-A7 but not inactive Ceapin-A5 (Figure 2.13D). Thus, consistent with 
the above experiments where organelle tethering was not required, these results 
confirm that no other ER proteins are required for Ceapin-A7 induced ATF6α and 
ABCD3 physical association.  
Finally, we tested whether purified ATF6α and ABCD3 were sufficient for Ceapin-
induced tethering. In a binding assay with purified ATF6α(2-90) and ABCD3, our vehicle 
(DMSO) and inactive Ceapin-A5 controls did not induce ATF6α(2-90) and ABCD3 
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binding (Figure 2.13E). In the presence of Ceapin-A7, however, the cytosolic domain of 
ATF6α(2-90) and ABCD3 associated in solution (Figure 2.13E). Thus, Ceapin is directly 
responsible for tethering ABCD3 to ATF6α. 
 
Discussion 
 Ceapins, named for their ability to trap ATF6α in the ER, act with exquisite 
selectivity; they do not affect signaling of ATF6α’s close homolog ATF6b or SREBP 
(sterol response element binding protein) (Gallagher et al., 2016), which depend on 
broadly used vesicular trafficking ER-Golgi pathways and are activated by the same 
Golgi-resident proteases (Nadanaka et al., 2004; Okada et al., 2003; Schindler and 
Schekman, 2009; Ye et al., 2000).  Here we discovered the basis of this specificity. 
Ceapins induce neomorphic inter-organelle junctions, forcing interactions between the 
cytosolic domain of ER-tethered ATF6α and the peroxisomal transmembrane protein 
ABCD3 to sequester ATF6α from its normal trafficking route (Figure 2.14), and do so 
without interfering with or depending on ABCD3’s normal function. Since ABCD3 protein 
expression is ten-fold higher than ATF6 (Hein et al., 2015), it is likely ABCD3 is not 
saturated. Ceapin induced interaction of ABCD3 with the most N-terminal region of 
ATF6α also clarifies how ATF6α foci are excluded from COPII trafficking, while the 
transmembrane region of ATF6α remains accessible to protease cleavage. 
Mechanistically, Ceapins could act as molecular staples that physically bridge the 
respective proteins or bind to one or the other inducing allosteric changes that promote 
their association; but in either case, Ceapin is responsible for tethering ABCD3 to 
ATF6α.  
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Remarkably, in the absence of Ceapins, ATF6α and ABCD3 localize to different 
parts of the cell and are not known to interact physically or functionally. Indeed, an 89-
amino acid fragment of ATF6α fused to GFP is sufficient to recruit GFP to peroxisomes, 
ruling out the need for endogenous inter-organellar tethers. This Ceapin-induced 
tethering enables an “anchor away” strategy but one that uses an abundant, 
ubiquitously expressed endogenous acceptor protein. There has been increasing 
interest in small molecules that induce novel protein-protein interactions with therapeutic 
potential (De Waal et al., 2016; Han et al., 2017; Krönke et al., 2014; Lu et al., 2014; 
Petzold et al., 2016; Uehara et al., 2017). Ceapins provide a novel example of such 
molecules and increase the repertoire to include the induction of inter-organellar 
connections, opening new mechanistic routes for drug development and synthetic 
biology by broadly enabling control of protein function through chemical-induced 
misdirection.  
Understanding the mechanism of action of a chemical modulator of cellular 
stress and establishing that it is acting directly and specifically is critical for exploiting 
the utility of any stress modulators either as research or potential therapeutic agents. 
Our identification of the mechanism by which Ceapins achieve their remarkable 
specificity forms a foundation to explore the utility of ATF6α inhibition in the treatment of 
cancers, such as squamous carcinomas, in which ATF6α signaling protects dormant 
tumor cells from classical chemotherapies (Schewe and Aguirre-Ghiso, 2008).  
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FIGURES 
 
Figure 2.1. ABCD3 KD desensitizes cells to Ceapin-A7. 
 (A) Schematic of the ER stress element (ERSE) reporter cassette. K562 ERSE reporter 
cells were transduced with the indicated sgRNAs and treated with vehicle (DMSO) or 
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tunicamycin (Tm) (6 µg/ml) for 16 h. (B) Schematic of the CRISPRi screen to identify 
the target of Ceapin. K562 cells expressing the ERSE reporter were transduced with the 
sgRNA library. The population was then divided into two subpopulations, which were 
treated with Tm or Tm plus Ceapin-A7 at EC90 (3 µM) for 16 h. Cells in the top and 
bottom thirds of mCherry fluorescence of each subpopulation (Tm-treatment and Tm + 
Ceapin-treatment) were collected by FACS and processed to measure the frequencies 
of sgRNAs contained within each. (C) Volcano plot of gene-reporter phenotypes and p 
values from CRISPRi screen. Negative control sgRNA targeted genes (grey), Ceapin-
independent genes (red), genes with growth phenotypes (blue), and Ceapin hits (black) 
are indicated.  denotes chromatin architecture and remodeling related genes that 
impact reporter transcription. (D) K562 ERSE reporter cells with individual ABCD3 
sgRNAs or control sgRNA (NegCtrl) were treated with Tm and increasing 
concentrations of Ceapin-A7 for 16 h.  Reporter fluorescence was measured by flow 
cytometry and median values were plotted (N = 3, ± SD). (E) K562 ERSE reporter 
ABCD3 and NegCtrl KD cells were treated with DMSO or Tm and reporter activation 
was measured as in (D). (F and G) qPCR analysis of ATF6α target genes HSPA5 and 
HSP90B1, respectively. HepG2 CRISPRi NegCrl and ABCD3 KD cell lines were treated 
with DMSO, thapsigargin  (Tg) (100 nM), and Tg with Ceapin (6 µM). Tg blocks the ER 
calcium pump and induces ER stress. Data plotted are mRNA levels for HSPA5 and 
HSP90B1 normalized to GAPDH and then compared to unstressed NegCtrl cells ± 
standard deviation of duplicate technical replicates of two biological replicates. 
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Figure 2.2. Genome-scale CRISPRi screen to identify molecular target of Ceapin 
(A and B)  K562 ERSE reporter cells were transduced with the indicated sgRNAs and 
treated with vehicle (DMSO) or tunicamycin (Tm) (6 µg/ml) for 16 h. (C) Reporter 
phenotypes from CRISPRi screens treated with ER stress in the absence (x-axis) and 
presence (y-axis) of Ceapin. Ceapin-independent genes (labeled in red) are genes 
whose knockdown changed the expression of the reporter to the same degree in both 
treatments and localized to the diagonal. Genes with growth phenotypes of at least -
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0.19 in previous growth screens (Horlbeck et al., 2016) are labeled in blue.  denotes 
chromatin architecture and remodeling related genes that impact reporter transcription. 
Negative control genes are labeled in grey. (D) Volcano plot of gene-reporter 
phenotypes and p values from CRISPRi screen described in (Figure 2.1C) and shown 
on y-axis of (A) with additional genes labeled.  
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Figure 2.3. ABCD3 KD does not affect ATF6α nuclear translocation.  
Quantification of nuclear translocation of ATF6α. Endogenous ABCD3 was knocked-
down in 3xFLAG-ATF6α HEK293 CRISPRi cells and full length GFP-ABCD3 construct 
was added back by FACS soring for narrow, low GFP levels. Data plotted is the ratio of 
ATF6α signal intensity of nucleus to ER per cell, from one of three independent 
experiments and with at least twenty cells per condition. Statistical analysis used 
unpaired two-tailed t-tests, **** indicates p < 0.0001.   
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Figure 2.4. ABCD3 is required for Ceapin-induced ATF6α foci.  
(A) HEK293 CRISPRi cells stably expressing doxycycline inducible 3xFLAG-ATF6α with 
ABCD3 or NegCtrl KD were treated either with DMSO or Ceapin (6 µM) for 30 min prior 
to fixation, staining with anti-ABCD3 and/or anti-PEX14, and confocal fluorescent 
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imaging. Scale bar, 10 µm. Images are representative of two independent experiments, 
in which we imaged at least 20 positions per well for each experiment. (B and C) Plotted 
is the mean and standard deviation of the mean per cell correlation of 3xFLAG-ATF6α 
and ABCD3 or PEX14 from (A) with at least 30 cells imaged per condition. All cells 
imaged in ABCD3 KD (96% KD), including wildtype cells, were used in quantification.  
Statistical analysis used unpaired two-tailed t-tests, **** indicates p < 0.0001.  (D) U2-
OS cells stably expressing GFP-ATF6α were treated either with vehicle (DMSO), Tg 
(100 nM), Tm (2 µg/ml), or Ceapin (6 µM) for 2 h or 4 h (shown) prior to fixation, co-
staining with anti-ABCD3 and anti-PEX14, and fluorescent imaging. Stress attenuated 
GFP-ATF6α foci are indicated by arrowheads. Scale bar, 10 µm. (E) Quantification of 
correlation of GFP-ATF6α and ABCD3 within PEX14 sites.  
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Figure 2.5. ABCD3 is not co-translationally translocated into the ER.  
Data from Jan et al. 2014 is plotted. Gene enrichments obtained with the general BirA-
Sec61b ER marker in HEK293 cells and signal sequence (SS) annotations predicted by 
SignalP. ABCD4 was previously annotated to be peroxisomal, but recently shown to be 
ER localized. PEX16 has been previously shown to be co-translationally translocated. 
PXPM2 is a peroxisomal membrane protein.  
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Figure 2.6. Ceapin-induced ATF6α foci colocalize with peroxisomal matrix protein 
Thiolase.  
(A) 3xFLAG-ATF6α HEK293 CRISPRi cells with NegCtrl KD were treated and fixed as 
in Figure 2.2A and stained for Thiolase. Scale bar, 10 µm. (B) Quantification of the 
correlation of ATF6α and Thiolase from (A) and plotted as in Figure 2.4B. 
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Figure 2.7. PEX19 KD desensitizes cells to Ceapin and is required for Ceapin-
induced ATF6α foci 
(A) K562 ERSE reporter cells with NegCtrl or PEX19 sgRNA KD were treated with ER 
stressor (6 µg/ml Tm) and increasing concentrations of Ceapin-A7 for 16 h.  Reporter 
fluorescence was measured by flow cytometry and median values were plotted (N = 3, ± 
SD). (B) K562 ERSE reporter PEX19 and NegCtrl KD cells were treated without 
(DMSO) or with ER stressor (Tm) and reporter activation was measured as in (A). (C) 
3xFLAG-ATF6α HEK293 CRISPRi cells with PEX19 sgRNA or NegCtrl KD were 
treated, fixed, and stained as in Figure 2.2A. Scale bar, 10 µm.  
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Figure 2.8. Ceapin treatment does not inhibit ABCD3 activity  
Bile acid levels were measured in HepG2 CRISPRi cells with NegCtrl or ABCD3 KD 
treated with vehicle (DMSO), EC50 of Ceapin (600nM), and ten times the EC50 of 
Ceapin-A7 (6 µM).  
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Figure 2.9. Ceapin-induced ATF6α-ABCD3 interaction does not require known ER-
peroxisome tethers  
(A) ER tether components, VAPA and VAPB, and peroxisome tether components, 
ACBD4 and ACBD5, were individually knocked-down in 3xFLAG-ATF6α HEK293 
CRISPRi cell line, treated, fixed, and stained as in Figure 2.2A prior to fluorescence 
imaging. Scale bar, 10 µm. (B) Quantification of the correlation of ATF6α and ABCD3 
from (A) and plotted as in Figure 2.2B. (C) K562 ERSE reporter cells with NegCtrl or 
indicated knockdowns were treated with Tm and increasing concentrations of Ceapin-
A7 for 16 h.  Reporter fluorescence was measured by flow cytometry and median 
values were plotted (N = 3, ± SD). 
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Figure 2.10. Ceapin-induced interactions do not require ER localized ATF6α nor 
ABCD3 transporter activity 
(A) Diagram of GFP-ATF6α constructs tested. A nuclear exit signal (NES) was added to 
ATF6α truncated constructs to retain ATF6α in the cytosol. Endogenous ATF6α was 
knocked-down in 3xFLAG-ATF6α HEK293 CRISPRi cells grown without doxycycline, so 
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that only GFP-ATF6α constructs were expressed. GFP-ATF6α-truncated cell lines were 
treated with DMSO or Ceapin-A7, fixed and stained for ABCD3. Scale bar, 10 µm. (B) 
Quantification of the correlation of GFP-ATF6α within ABCD3 sites. (C) Diagram of the 
GFP-ABCD3 mutants and truncations tested. Endogenous ABCD3 was knocked-down 
in 3xFLAG-ATF6α HEK293 CRISPRi cells so only GFP-ABCD3 constructs were 
expressed. GFP-ABCD3 cell lines were treated with DMSO or Ceapin-A7, fixed and 
stained for  FLAG(ATF6α) (shown) and PEX14. Scale bar, 10 µm. (D) Quantification of 
the correlation of GFP-ABCD3 and 3xFLAG-ATF6α within PEX14 sites.  
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Figure 2.11. ATF6α(2-90) colocalizes with peroxisomal matrix protein Thiolase  
(A) Endogenous ATF6 was knocked-down in U2OS Flp-In™ CRISPRi cells and FACS 
sorted for narrow, low GFP levels so only GFP-ATF6α(2-90) construct was expressed. 
Cells were treated and fixed as in Figure 2.2A and stained for Thiolase. Scale bar, 10 
µm. (B) Quantification of the correlation of ATF6α and Thiolase from (A) and plotted as 
in Figure 2.2B. 
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Figure 2.12. ABCD3 constructs localization to peroxisome. 
Endogenous ABCD3 was knocked-down in 3xFLAG-ATF6α HEK293 CRISPRi cells and 
FACS sorted for narrow, low GFP levels so only GFP-ABCD3 constructs were 
expressed. GFP-ABCD3 cell lines were treated with DMSO or Ceapin-A7, fixed and 
stained for PEX14 (shown) and FLAG(ATF6α). Scale bar, 10 µm. 
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Figure 2.13. Ceapin drives ATF6α-ABCD3 interaction in cells and in vitro. 
(A and B) Proteomic analysis and immunoblot (IB) of anti-FLAG affinity purification from 
3xFLAG-ATF6α HEK293 cells treated with stress (100nM Tg) and inactive Ceapin-A5 
analog (6µM) or active Ceapin-A7 (6µM)  with two replicates for each treatment 
condition. SQSTM1 KD ( ) was the top second hit in proteomics, however, SQSTM1 
KD in the K562 ATF6 reporter cell line did not render cells resistant to Ceapin treatment 
and retained a similar response to negative control cells. I, input; FT, flow-through; E, 
elution.  (C) Immunoprecipitation of full-length GFP-ABCD3 and GFP-ABCD3DNBD 
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from cells treated with DMSO or Ceapin-A7. (D) Detergent solubilized GFP-ATF6α(2-
90) or GFP-only cell lysates were incubated with Ceapin-A7 or inactive analog Ceapin-
A5 and affinity purified with anti-GFP. (*) Indicates a degradation product. (E) Purified 
ATF6α-MBP and ABCD3-GFP were incubated with inactive Ceapin-A5 or active 
Ceapin-A7 and affinity purified with anti-MBP antibody.  
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Figure 2.14. Model for Ceapin induced ATF6α inhibition. 
Ceapins sequester ATF6α into a transport-incompetent pool during ER stress by 
tethering ATF6α to peroxisomal ABCD3. ATF6α is occluded from COPII trafficking, 
while its transmembrane domain remains accessibly to protease cleavage. 
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MATERIALS AND METHODS 
 
Cell culture and experimental reagents 
U2OS, 293TREx, and HepG2 cells were cultured in DMEM. K562 cells were cultured in 
RPMI. Culture media was supplemented with 10% fetal bovine serum (FBS), 1% L-
glutamine, and 1% penicillin/streptomycin (ThermoFisher). U2-OS cells stably 
expressing GFP-HsATF6α were purchased from Thermo Scientific (084_01) and - 
further supplemented with 500 µg/ml G418 to maintain GFP-HsATF6α expression. 
HeLa CRISPRi cells expressing SFFV-dCas9-BFP-KRAB were previously described 
(Jost et al., 2017). Tunicamycin and thapsigargin were purchased from Sigma. 
Antibodies used were rabbit anti-GFP (ThermoFisher A11122), mouse anti-FLAG M2 
(Sigma F1804), rat anti-GRP94 9G10 (abcam ab2791), rabbit anti-pmp70 (ab109448) 
for PFA fixation and (PA1-650) for methanol fixation, mouse anti-pmp70 (ab211533) for 
PFA fixation and (SAB4200181) for methanol fixation.  
 
Generation of constructs and cell lines  
To generate CRISPRi knockdown cell lines, SFFV-dCas9-BFP-KRAB (Addgene 46911) 
or UCOE-EF1α-dCas9-BFP-KRAB (Jost et al., 2017) were stably transduced and 
FACS-sorted for BFP positive cells. 293 TREx cells expressing doxycycline-inducible 
6xHis-3xFLAG-HsATF6α (Gallagher et al., 2016) were infected with SFFV-dCas9-BFP-
KRAB and sorted twice for BFP expressing cells. HepG2 cells from ATTC (CRL-10741) 
were infected with UCOE-EF1α-dCas9-BFP-KRAB and FACS sorted for BFP 
expression. The ERSE reporter construct was generated by subcloning mCherry into 
the ERSE.Fluc.pcDNA3.1 (Mortenson et al. 2017) using the polymerase incomplete 
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primer extension method to replace the FLuc gene. This construct was then subcloned 
into ClaI and EcoRI digested pLenti6.V5.GFP. K562 cells stably expressing dCas9-
KRAB (Gilbert et al., 2014) were stably transduced with the ERSE reporter construct 
and a monoclonal line was selected and expanded to generate K562 ERSE reporter cell 
line.  
 
Individual gene knockdowns were carried out by selecting sgRNA protospacers from 
compact hCRISPRi-v2 library and cloning into lentiviral plasmid pU6-sgRNA EF1α-puro-
t2a-BFP (Addgene 60955) as previously described (Horlbeck et al., 2016). Protospacer 
sequences used for individual knockdowns are listed in Table 2.1. The resulting sgRNA 
expression vectors were packaged into lentivirus by transfecting HEK293T with 
standard packaging vectors using TransIT®-LTI Transfection Reagent (Mirus, MIR 
2306). The viral supernatant was harvested 2-3 days after transfection and frozen prior 
to transduction into CRISPRi knockdown cell lines described above. 
 
3xFLAG-ATF6α HEK293 CRISPRi described above was stably transduced with sgRNA 
knockdown of endogenous ATF6α or ABCD3 and grown without doxycycline to 
ascertain that only truncation constructs would be expressed. ATF6α truncation 
constructs were generated by Gibson assembly of IDT gblock of sfGFP and ATF6α 
PCR amplified from peGFP-HsATF6α (Addgene #32955) into inserted into BamHI/NotI 
digested pHR-SFFV-Tet3G (Gilbert et al., 2014). ATF6α truncations were PCR 
amplified with reverse primers containing nuclear exit signal (NES) (NES, 
CTGCCCCCCCTGGAGCGCCTGACCCTG; NES_REV, 
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CCCCTGCAGCTGCCCCCCCTGGAGCGGCTGACCCTG) to retain ATF6α in the 
cytosol. Full length GFP-ABCD3 and GFP-ABCD3DNBD (2-416) were cloned by Gibson 
assembly of ABCD3 PCR amplified from cDNA and IDT gblock of sfGFP into 
BamHI/NotI digested pHR-SFFV-Tet3G (Gilbert et al., 2014). ABCD3 G478R and S572I 
mutations were generated by site directed mutagenesis (QuikChange Lightning Agilent) 
of full-length GFP-ABCD3 construct. ATF6α and ABCD3 truncation vectors were 
packaged into lentivirus as described above, stably transduced, and FACS sorted for a 
narrow and low level of GFP expression. 
 
U2OS Flp-In™ cells were infected with UCOE-EF1α-dCas9-BFP-KRAB and FACS 
sorted for BFP expression. They were then stably transduced with sgRNA knockdown 
of endogenous ATF6α and GFP-ATF6α(2-90) construct, and FACS sorted for a narrow 
level of GFP expression. Parental cell lines and commercially available cell lines were 
authenticated by STR analysis and tested negative for mycoplasma contamination. 
 
Genome-scale CRISPRi screen  
Reporter screens were carried out using protocols similar to those previously described 
(Adamson et al., 2016; Gilbert et al., 2014; Sidrauski et al., 2015). The compact (5 
sgRNA/gene) hCRISPRi-v2 (12) sgRNA libraries were transduced into ERSE reporter 
cells at a MOI <1 (55% BFP+ cells). Cells were grown in spinner flasks for 2 days 
without selection, selected with 2 µg/ml puromycin for 2 days, and allowed to recover for 
3 days. Cells were then split into two populations, which were treated for 16 h with 6 
µg/ml tunicamycin alone or 6 µg/ml tunicamycin and 3 µM Ceapin (EC90). Cells were 
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then sorted based on reporter fluorescence using BD FACS Aria2. Cells with the 
highest (~30%) and lowest (~30%) mCherry expression were collected and frozen after 
collection. Approximately 20 million cells were collected per bin. Genomic DNA was 
isolated from frozen cells, and the sgRNA-encoded regions were enriched, amplified, 
and prepared for sequencing.  
 
Sequenced protospacer sequences were aligned and data were processed as 
described (Gilbert et al., 2014; Horlbeck et al., 2016) with custom Python scripts 
(available at https://github.com/mhorlbeck/ScreenProcessing). Reporter phenotypes for 
library sgRNAs were calculated as the log2 enrichment of sgRNA sequences identified 
within the high-expressing mCherry over the low-expressing mCherry cells. Phenotypes 
for each transcription start site were then calculated as the average reporter phenotype 
of all 5 sgRNAs. Mann-Whitney test p-values were calculated by comparing all sgRNAs 
targeting a given TSS to the full set of negative control sgRNAs. For data presented in 
Figure 2.1B, screen hits are defined as those genes where the absolute value of a 
calculated reporter phenotype over the standard deviation of all evaluated phenotypes 
multiplied by the log10 of the Mann-Whitney p-value for given candidate is greater than 
7. Growth screen data (Horlbeck et al., 2016) was used to label genes with growth 
phenotype of at least -0.19. Ceapin independent genes are defined as genes that were 
hits in tunicamycin alone and tunicamycin with Ceapin treatment since their phenotype 
was independent of Ceapin treatment. Genes involved in chromatin remodeling and 
architecture have been previously described in UPR screens to act downstream and 
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directly affect expression of the reporter (Jonikas et al., 2012). Chromatin related genes 
that impact reporter expression are labeled with ( ) in Figure 2.2D.  
 
Bile Acid Assay 
HepG2 CRISPRi ABCD3 KD and NegCtrl cells were treated with DMSO or Ceapin at 
600 nM or 6 µM for 24 h. Cells were harvested in scrapping buffer (cold PBS with 10 µM 
MG132 and 1X protease inhibitor), spun down, resuspended in lysis buffer (50 mM Tris 
pH 7.4, 150 mM NaCl, 5 mM EDTA, 1X protease inhibitor, and 1% LMNG), and spun 
down at 10,000 x g for 10 min. The supernatant was used for bile acid assay (Cell 
Biolabs STA-631) as described by the manufacturer.  
 
Quantitative RT-PCR 
Cells were harvested and total RNA was isolated using the NucleoSpin RNA II 
(Macherey-Nagel) according to manufacturer’s instructions. RNA was converted to 
cDNA using AMV reverse transcriptase under standard conditions with oligo dT and 
RNasin (Promega, Life Technologies). Quantitative PCR reactions were prepared with a 
2x master mix according to the manufacturer’s instructions (KAPA SYBR FAST qPCR 
Kit). Reactions were performed on a LightCycler thermal cycler (Roche). Primers used 
were against HSPA5 (forward, TGTGCAGCAGGACATCAAGT: reverse, 
AGTTCCAGCGTCTTTGGTTG ) and HSP90B1 (forward, 
GGCCAGTTTGGTGTCGGTTT ; reverse, CGTTCCCCGTCCTAGAGTGTT ).  
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Immunofluorescence  
Fluorescence confocal imaging was carried out as described in (10,11).  293 TREx, 
U2OS, HepG2, and HeLa cells were plated in 8-well ibiTreat μSlide (ibidi 80826) at 20-
25,000 cells/well. In 3xFLAG-ATF6α imaging experiments (Figure 2.4A-C, Figure 2.6-7, 
Figure 2.9A-C, Figure 2.10A-D, Figure 2.12), 3xFLAG-ATF6α HEK293 CRISPRi cells 
were plated and induced with 50nM doxycycline on the same day. On the following day, 
cells were treated with DMSO or 6µM Ceapin for 30 min and then fixed with cold 
methanol or 4% PFA. For cold methanol fixation, media was removed, cold ethanol was 
added for 3 min at -20° C, washed, and permeabilized with PHEM (60 mM PIPES, 
25 mM HEPES, 10 mM EGTA, 2 mM MgCl2, pH 6.9) with 0.1% Triton X-100, and 
washed twice with PHEM. For PFA fixation, media was removed from slides, 4% PFA 
(EMS) was added for 10 min at room temperature, washed, permeabilized as above, 
and washed with PHEM. Slides were then treated with blocking buffer (5% goat serum 
(Jackson ImmunoResearch) in PHEM) for 1 h at room temperature. Antibodies were 
diluted in blocking buffer and incubated with cells at 4° C overnight. After three washes 
with PHEM, cells were incubated with secondary antibodies conjugated to Alexa 488, 
Alexa 568, and/or Alexa 633 (Invitrogen) for 1 h at room temperature. Slides were 
imaged on a spinning disk confocal with Yokogawa CSUX A1 scan head, Andor iXon 
EMCCD camera and 100x ApoTIRF objective NA 1.49 (Nikon). Linear adjustments 
were made using ImageJ. Quantification of correlation between ATF6α with ABCD3, 
Thiolase, and/or PEX14 was calculated using CellProfiler 2.1.1. ABCD3 or PEX14 
images were used to identify objects, a background threshold for ATF6α images was 
set to 1.2, and clumped objects were separated based on intensity. The resulting 
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ABCD3, Thiolase, or PEX14 outlines were used as masks to count the ATF6α intensity 
within ABCD3, Thiolase, or PEX14. Data from CellProfiler was imported into GraphPad 
Prism version 6.0 for statistical analysis and plotting. 
 
Nuclear Translocation Assay  
3xFLAG-ATF6α HEK293 CRISPRi cells with ABCD3 KD and ABCD3 KD complemented 
with full length GFP-ABCD3 construct were plated in ibidi 96-well ibiTreat μ-plate (ibidi 
89626) and induced with 50nM doxycycline on the same day. On the following day, cells 
were treated with DMSO or 100 nM Tg for 2 hours and then fixed with 4% PFA as 
described above. The plates were then treated with blocking buffer (5% goat serum 
(Jackson ImmunoResearch) in PHEM) for 1 h at room temperature. Primary antibodies, 
mouse anti-FLAG M2 (Sigma F1804) and rat anti-GRP94 9G10 (abcam ab2791), were 
diluted in blocking buffer and incubated with cells at 4° C overnight. After three washes 
with PHEM, cells were incubated with secondary antibodies conjugated to Alexa 568 
and Alexa 633 (Invitrogen) and nuclear stain (DAPI, Molecular Probes D-1306, 5 μg/mL) 
for 1 h at room temperature. Quantification ATF6α signal in ER and nucleus was 
calculated using CellProfiler 2.1.1 as described in (Gallagher et al. 2016). DAPI images 
were used to identify primary objects and clumped objects were distinguished based on 
fluorescence intensity.  The GRP94 images were then used to generate secondary 
objects from primary objects using global Otsu two-class thresholding with weighted 
variance. The final ER mask was generated  by subtracting the nuclear area from the 
ER area. Lastly, the FLAG-ATF6α images were used to calculate FLAG-ATF6α intensity 
in the nucleus and ER and determine the nucleus to ER ratio of each cell.  Data from 
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CellProfiler was exported as a MATLAB file for analysis and plotted on GraphPad Prism 
version 6.0.  
 
Immunoprecipitation and Immunoblot Analysis  
Cells were grown in 100 mm plates with two replicates for each treatment condition, 
treated with 50 nM doxycycline the following day, treated with 100nM Tg and 6µM 
Ceapin-A5 or 6uM Ceapin-A7 for 30 min on the day of harvest, and harvested in 
scrapping buffer (cold PBS with 10 μM MG132 and 1X protease inhibitor).  Ceapin A-7, 
inactive analog Ceapin A-5, or DMSO were kept in scrapping and lysis buffers 
throughout IP.  Cells were lysed for 1 h at 4° C in lysis buffer (50 mM Tris pH 7.4, 150 
mM NaCl, 5 mM EDTA, 1X protease inhibitor, and 1% LMNG (Anatrace NG322)). The 
lysates were cleared by centrifugation at 17,000 x g for 30 min.  Dynabeads Protein-G 
(ThermoFisher) were bound with Sigma FLAG M2 antibody for 1 h at 4° C and 
crosslinked with 100 µM BS3 crosslinker for 30 min.  293 TREx 3XFLAG cell lysates 
were then incubated with these FLAG beads for 2 h at 4° C. IP beads were washed with 
wash buffer (lysis buffer without LMNG) and boiled and eluted in buffer containing 50 
mM Tris pH 6.8, 300 mM NaCl, 2% SDS, and 10 mM EDTA. Protein samples were then 
precipitated, trypsin digested, labeled with tandem mass tags (TMT), and analyzed by 
liquid chromatography-mass spectrometry using Multidimensional Protein Identification 
Technology (MuDPIT), as described previously (Mortenson et al. 2017; Plate et al. 
2018). TMT intensities for proteins detected in each channel were normalized to the 
respective TMT intensity of ATF6α. TMT ratios for individual proteins were then 
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calculated between Tg+Ceapin-A7/DMSO treatment or Tg+Ceapin-A5/DMSO 
treatment.  
 
The reciprocal affinity purification with full-length GFP-ABCD3 or GFP-ABCD3DNBD 
cells was carried out by culturing, treating, and lysing cells as described above. 293 
TREx 3XFLAG GFP-ABCD3 clarified cell lysate was then incubated with GFP-Trap_MA 
ChromoTek beads for 2 h at 4° C. IP beads were washed with wash buffer (lysis buffer 
without LMNG) and boiled in SDS sample buffer for 10 min.  
 
Cells for in vitro incubation were lysed with lysis buffer containing LMNG (described 
above) and cleared by centrifugation at 17,000 x g for 30 min in the absence of any 
drug. Cleared supernatant was then incubated with Ceapin A-7 or inactive analog 
Ceapin A-5 for 30 min at room temperature, bound to GFP-Trap_MA ChromoTek beads 
for 1 h at 4° C, washed with wash buffer containing Ceapin A-7 or Ceapin A-5, and 
eluted by boiling in SDS sample buffer.  
 
For in vitro binding studies with purified components, 6.25 nM 3XFLAG-ATF6α (2-90)-
TEV-MBP- HIS6X and 100 nM ABCD3-eGFP- HIS8X were incubated in lysis buffer (50 
mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 1X protease inhibitor, 0.001% LMNG) with 
15-90 µM Ceapin-A7 or inactive Ceapin-A5 for 30 min at room temperature. Samples 
were then incubated with MBP-Trap_A ChromoTek beads for 1 h at 4° C, washed with 
same buffer containing Ceapin A-7 or A-5 and 300 mM NaCl, and eluted by boiling in 
SDS sample buffer.  
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Samples were run on a precast 4%–12% Bis-Tris polyacrylamide gel (Life 
Technologies) under denaturing conditions and transferred to nitrocellulose membrane. 
Antibodies described above for FLAG, GFP, and Pmp70 (SAB4200181) were used to 
detect proteins and blots were imaged for chemiluminescence detection using a 
ChemiDocTM XRS+ Imaging System (Bio-Rad) (Figure 2.13B, 2.13D-E) or LICOR 
system (Figure 2.13C).  
 
Generation of recombinant proteins  
Human ATF6α(2-90) with an N-terminal 3XFLAG was cloned into pET16b-TEV-MBP-
HIS6X (Novagen) using Gibson assembly. The construct was expressed in in BL21-
Gold(DE3) E. coli cells, grown to 0.6-0.8 OD 600, and induced overnight at 16° C with 
0.25 mM IPTG (Gold Biotechnology). The cells were harvested and resuspended in 
buffer containing 50 mM HEPES pH 7, 150 mM NaCl, 10% glycerol, 2 mM TCEP, and 
complete EDTA-free protease inhibitor cocktail (Roche). After lysis by sonication, the 
lysate was clarified at 30,000 x g for 30 min at 4° C. The clarified lysate was loaded onto 
a HisTrap HP 5 ml column, washed in binding buffer (50 mM HEPES, pH 7, 300 mM 
NaCl, 1 mM TCEP, 10% glycerol, and 25 mM imidazole), and eluted with a linear 
gradient of 25 mM to 1M imidazole in the same buffer. The ATF6α fractions eluted at 
240 mM imidazole were collected and concentrated with an Amicon Ultra-15 
concentrator (EMD Millipore) with a 30,000-dalton molecular weight cutoff. The ATF6α 
concentrated fraction was loaded onto a Mono Q HR16/10 column (GE Healthcare), 
washed in Buffer A (50 mM HEPES, pH 7.5, 100 mM NaCl, 10% glycerol, and 1 mM 
49 
DTT) and eluted with a linear gradient of 100 mM to 1M NaCl in the same buffer. 
Fractions were collected, concentrated as above, and loaded onto a Superdex 200 
10/300 GL column (GE Healthcare) equilibrated with buffer containing 30 mM HEPES, 
pH 7.5, 300 mM NaCl, 5% glycerol, and 1 mM DTT.  
 
Expression and purification of human ABCD3: Full-length human ABCD3 isoform I was 
synthesized and cloned into modified pFastBac1 plasmid with a C-terminal -eGFP -
8XHis-tag for baculoviral expression in Spodoptera frugiperda SF9 cells. Bacmid DNA 
was produced by transforming the recombinant pFastBac1 plasmid into E. coli 
DH10Bac strain. To express the protein, SF9 cells were infected with the bacmid made 
from recombinant pFastBac1 plasmid at multiplicity of infection (MOI) = 2 for 48 h at 27° 
C. The cells were harvested and resuspended in lysis buffer (50 mM Tris Cl, pH 7.5, 
100 mM NaCl, 100 mM MgCl2, 10% glycerol) containing complete EDTA-free protease 
inhibitor cocktail (Roche), and lysed by sonication. The lysate was centrifuged at 
186,010 x g for 2 h to extract the membrane fraction. 3 g of the membrane was 
solubilized in 30 ml of lysis buffer containing 1% w/v lauryl maltose neopentyl glycol 
(LMNG) (Anatrace): 0.1% w/v cholesteryl hemisuccinate (CHS) (Anatrace) overnight. 
Solubilized membrane was clarified by centrifugation at 104,630 x g for 30 min with 5 
mM imidazole added. A HiTrapTM TALON® crude 1 ml column (GE Healthcare) was 
equilibrated with the lysis buffer containing 5 mM imidazole and solubilized membrane 
loaded onto the column. After binding the column was washed with 15 ml of 10 mM 
imidazole, 0.02% glyco-diosgenin (GDN) (Anatrace) in lysis buffer. The protein was 
eluted from the column with 10 ml of 150 mM imidazole, 0.02% GDN containing lysis 
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buffer. The protein obtained was concentrated using Amicon Ultra-15 centrifugal filter 
units (MilliporeSigma) and size exclusion chromatography was done to further purify the 
protein in SEC buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 2 mM MgCl2, 2% glycerol 
and 0.02% GDN).  
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TABLES 
 
Table 2.1. Protospacer sequence of sgRNAs 
Gene Protospacer 
NegCtrl GCGCCAAACGTGCCCTGACGG 
ATF6 GTGGGATCTGAGAATGTACCA 
ABCD3-1 GGTACCAGCGAGCCGGCGAG 
ABCD3-2 GACTGCCGGTACCAGCGAGC 
PEX19-1 GGCCGAAGCGGACAGGGAAT 
PEX19-2 GGAGGAAGGCTGTAGTGTCG 
ACBD4 GCCGGCCCTGCTGGACCCCG 
ACBD5 GGGAGCCGCTCTCCCACCCT 
VAPA GCACCGAACCGGTGACACAG 
VAPB GCGGGGGTCCTCTACCGGGT 
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When we started this work, we sought to uncover the mechanism of ATF6α 
activation and trafficking. Ceapins provided an exciting new tool to probe ATF6α in the 
ER. Ceapins specifically retain ATF6α in the ER in the presence of stress in foci that 
resembled the stress-attenuated foci of ATF6α (Gallagher et al., 2016). In uncovering 
the molecular target of Ceapin, we expected to converge on a key component of ATF6α 
regulation. We took an unbiased approach by carrying out genome-wide CRISPRi 
screen and proteomic analysis to identify the target of Ceapin. Although our reporter 
only had a ~two-fold induction, it was dependent on ATF6α and was sufficient to screen 
with. Unexpectedly, ABCD3 and PEX19 scored as the top hits from the genetic screen, 
hinting that peroxisomal ABCD3 was important for Ceapin action. ABCD3 also scored 
as a hit from the proteomics indicating Ceapin induced a physical interaction between 
ATF6α and ABCD3. Since PEX19 is cytosolic and is required for the initial targeting of 
ABCD3 to the peroxisome (Kashiwayama et al., 2007; Kashiwayama et al., 2005; 
Sacksteder et al., 2000), it was not expected that PEX19 also physically interact and 
score as a hit in the proteomics.  
Since ATF6α relies on general trafficking and processing machinery, it remained 
unclear how Ceapins achieved their specificity. We were able to reconstitute this 
interaction in vitro showing Ceapin was responsible for tethering ABCD3 to ATF6α. We 
found that ABCD3 does not play a role in ATF6α activation or attenuation, disproving 
our initial assumption.  Ceapin is able to act so selectively not because it targets a 
component of the ATF6α pathway, but rather because it sequesters ATF6α with a 
protein it does not normally interact with and localizes to a different part of the cell.  
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 We defined most N terminal cytosolic domain of ATF6α and the transmembrane 
region of ABCD3 as the minimal domains required for Ceapin induced interactions. 
Since there is currently no structure for either protein, future structural work of the 
ATF6α-ABCD3-Ceapin complex will provide additional understanding. We attempted to 
further truncate ATF6α(2-90) (ATF6α(2-45), ATF6α(45-90), or ATF6α(15-60)), but these 
constructs were not sufficient to form foci. Since ABCD3 is a transporter we determined 
that ABCD3 catalytic activity was not required for Ceapin action. We were hesitant to 
pursue further truncations of the ABCD3 transmembrane region because they could 
produce a misfolded or otherwise nonfunctional protein. It would be unclear if the 
ATF6α-ABCD3-Ceapin interaction failed to form because we defined a necessary 
domain or whether the ABCD3 truncations compromised ABCD3 structure globally. 
Once future work provides a structural understanding of the ATF6α-ABCD3-Ceapin 
complex, targeted mutations of specific residues should be carried out.  
 While the Ceapin induced ATF6α-ABCD3 interaction did not require the close 
proximity of the ER and the peroxisome, it is unclear if prolonged Ceapin treatment 
increases ER-peroxisome contacts. Ceapin induced foci persist for 24 hours (Gallagher 
et al., 2016), although longer time points have not been conducted. During a 30 min 
treatments of Ceapin-A7, the distribution of PEX14 or Thiolase positive peroxisomes did 
not visibly change. We specifically tested whether Ceapin-A7 treatment affected ABCD3 
activity. In these longer 24 h treatments, Ceapin did not inhibit ABCD3 activity in cells. 
In order to determine and quantify if peroxisome distribution changes during prolonged 
Ceapin treatment, higher resolution imaging is required. If Ceapin does affect the 
distribution of peroxisomes or increase the ER-peroxisome contact sites, Ceapin could 
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be beneficial in cells where the ER-peroxisome tethers are mutated or absent. However, 
depletion of ER-peroxisome tethers, ACBD5 or  VAPA/VAPB, also leads to a reduction 
of total ether lipids and cholesterol (Costello et al., 2017; Hua et al., 2017). It is thus 
unclear if Ceapin treatment alone would be enough compensate for the lipid transfer 
activity. Since disrupting ER-peroxisome contacts also leads to increased peroxisomal 
motility (Costello et al., 2017; Hua et al., 2017), it would also be informative to determine 
if prolonged Ceapin treatment also influences peroxisome dynamics. 
We describe a novel mechanism of a small molecule driving inter-organelle 
junctions to sequester one of the sensors of the unfolded protein response. We were 
able to recruit GFP to peroxisomes with the minimal GFP- ATF6α(2-90) construct and 
this approach could be applied to anchor away other proteins. Additionally, ATF6α(2-90) 
can be differentially localized to different organelles to induce tethering of peroxisomes 
to other organelles. In preliminary experiments targeting ATF6α(2-90) to the plasma 
membrane, Ceapin induced recruitment of peroxisomes to the plasma membrane. 
Utilizing Ceapin to sequester proteins will also require the development of Ceapin 
analogs that do not target endogenous ATF6α. Ultimately, a structural understanding of 
the ATF6α-ABCD3-Ceapin complex will inform the synthesis of new Ceapin derivatives. 
 Lastly, the machinery and regulatory components of the ATF6α pathway still 
remain unclear. While this work focused on the screen data set in the presence of 
Ceapin, the stress alone data set also warrants further investigation. Trafficking 
adaptors like the TMED proteins seemed promising candidates, but require further 
validation. Since ATF6α processing requires general ER to Golgi trafficking machinery 
and Golgi proteases, it is possible that additional components will also be utilized by 
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other ATF6 family members. Whether ATF6α directly senses unfolded proteins is also 
unknown. Additionally, the attenuated state of ATF6α remains poorly understood. It will 
be interesting to determine how ATF6α is activated and inactivated and contribute to 
increasing body of work highlighting the importance of ATF6α.  
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